menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Potential Future Treatments for Human Papilloma Virus (HPV)

close
Potential Future Treatments for Human Papilloma Virus (HPV)
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    While vaccines have emerged to treat a cancer caused by human papilloma virus, there is still a need for therapies to treat cancerous tissue caused by HPV. John Docherty, president of Toronto-based Helix BioPharma, tells host Bruce Japsen about his company's research and that of the biotech industry in the study and treatment of HPV, a key virus in the development of cervical cancer.

Presenters

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    While vaccines have emerged to treat a cancer caused by human papilloma virus, there is still a need for therapies to treat cancerous tissue caused by HPV. John Docherty, president of Toronto-based Helix BioPharma, tells host Bruce Japsen about his company's research and that of the biotech industry in the study and treatment of HPV, a key virus in the development of cervical cancer.

Presenters

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 5/30/20